Navigation Links
Panacea Pharmaceuticals, Inc. Presents Data That Its Cancer Biomarker HAAH is Readily Detectable in Serum Exosomes
Date:3/30/2017

GAITHERSBURG, Md., March 30, 2017 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. presents a paper regarding detection of the cancer biomarker HAAH at the annual American Association for Cancer Research (AACR) meeting in Washington DC held April 1-5, 2017. The paper is titled:

"Improved Detection of Cancer Specific Serum Exosomal Aspartyl (Asparaginyl) beta Hydroxylase (HAAH)"

The paper demonstrates major refinements to Panacea's multi-cancer HAAH-exosome detection assay that targets the cancer-specific blood serum biomarker HAAH. The cancer field is intensely focused upon exosomes, which are small cell-like nanoparticles derived from the cancer cells that are proving to be important biomarkers and mediators of cancer cell metastasis and progression.

The association of Panacea's target molecule HAAH with exosomes has led to a better individual understanding of these biomarkers as well as further development of a markedly improved diagnostic test with higher sensitivity and specificity than previous versions of the assay.

"We are excited to report our continued advances in the understanding of the role of serum exosomes in the detection and monitoring of cancer," said Hossein Ghanbari, Ph.D., CEO and CSO of Panacea.

About Panacea Pharmaceuticals, Inc.

Panacea Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel biologically targeted cancer therapies and diagnostics for unmet medical needs and is headquartered in Gaithersburg, Md. The company has recently initiated a Phase 1 trial of its PAN-301-1 therapeutic cancer vaccine in prostate cancer patients and has late-nonclinical stage projects in serodiagnosis of cancer, immuno-imaging of cancer, monoclonal antibody-based immunotherapy of cancer and neuroprotection, specifically in prevention of chemotherapy-induced cognitive impairment and peripheral neuropathy.

Contact:  Steven Fuller, Panacea Pharmaeceuticals, Inc., 240-454-8010, sfuller@panaceapharma.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/panacea-pharmaceuticals-inc-presents-data-that-its-cancer-biomarker-haah-is-readily-detectable-in-serum-exosomes-300431997.html


'/>"/>
SOURCE Panacea Pharmaceuticals, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Goodwin Biotechnology was Selected by Panacea Pharmaceuticals for a Highly Specialized Vaccine Fill / Finish Project
2. Panacea Pharmaceuticals Engages Accelovance For Clinical Development Of Its Novel Nanoparticle-Based Therapeutic Cancer Vaccine
3. Panacea Pharmaceuticals Presents Three Papers Regarding Its Nanoparticle-Based Therapeutic Cancer Vaccine at the Society for Immunotherapy of Cancer Annual Meeting at National Harbor, MD
4. OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Year End 2016
5. Company Of Murdered California Urologist, Absorption Pharmaceuticals, Files Suit Against Multi-National Maker Of Everyday Household Products For Trade Secret Theft And Fraud
6. Provectus Biopharmaceuticals, Inc. Announces Extension of Rights Offering
7. Cornerstone Pharmaceuticals, Inc. Announces the Addition of World-Renowned Experts to Scientific and Medical Advisory Boards
8. Purcell Julie & Lefkowitz LLP Is Investigating HedgePath Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
9. SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Anthera Pharmaceuticals, Inc. (ANTH)
10. Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
11. EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. - ALXN
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2019)... (PRWEB) , ... October 18, 2019 , ... Beginnings Treatment ... to act as the official sponsor of the Alcohol and Other Drug Awareness ... to empower students to make informed decisions around alcohol and other drugs through individual ...
(Date:10/19/2019)... ... October 19, 2019 , ... A popular performer and ... of educational programming. "Behind the Scenes" with Laurence Fishburne has the goal of educating ... large today. Recently, the show has turned its attention to the world of healthcare. ...
(Date:10/17/2019)... ... ... prominent features on a person is the ears. There are times when people are born ... This can cause a great deal of embarrassment to teens as well as adults so ... In order to help patients get the change they desire when it comes to the ...
Breaking Medicine Technology:
(Date:10/19/2019)... ... ... Today, Guide Dogs for the Blind (GDB), the national nonprofit ... people, guide dogs and communities, kicks off the organization’s momentous, weekend-long 2019 Guide Dogs ... community for the event to celebrate GDB’s mission and to experience what the city ...
(Date:10/17/2019)... ... October 17, 2019 , ... Knotty Roller, the affordable all-in-one muscle recovery ... campaign goal– raising more than $20,000 in only eleven hours after launching on ... be the first to enjoy the ease of use and versatility of our product,” ...
(Date:10/17/2019)... ... October 17, 2019 , ... A clinical article reviewing the ... Cosmetic Surgery Paper Award at Plastic Surgery - The Meeting 2019 in San Diego ... 6 Years,” was authored by Larry S. Nichter, M.D., Robert A. Hardesty, M.D., and ...
(Date:10/15/2019)... ... October 14, 2019 , ... Khalieghya Dandie-Evans, a liver ... ride atop the Donate Life Rose Parade® float in the 131st Rose Parade® on ... tissue donation across Northern California and Northern Nevada, the organization’s service area. , Khalieghya, ...
(Date:10/15/2019)... CHURCH, Va. (PRWEB) , ... October 15, 2019 ... ... Products:, Complying with FDA’s Most Recent IFU Guidance , **An FDAnews Webinar**, Tuesday, ... the recent Instructions for Use (IFU) guidance have on new drug applications and ...
Breaking Medicine News(10 mins):